{"id":64209,"date":"2025-01-31T12:01:34","date_gmt":"2025-01-31T12:01:34","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/01\/31\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/"},"modified":"2025-01-31T12:01:34","modified_gmt":"2025-01-31T12:01:34","slug":"okyo-pharma-announces-chairman-and-ceo-acquire-shares","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/","title":{"rendered":"OKYO Pharma Announces Chairman and CEO Acquire Shares"},"content":{"rendered":"<div>\n<p align=\"justify\">LONDON and NEW YORK, Jan.  31, 2025  (GLOBE NEWSWIRE) &#8212; OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease (DED), a multi-billion-dollar market, announced today that it has been notified that the Chief Executive Officer, Gary S. Jacob, has purchased 10,000 of the Company\u2019s ordinary shares on NASDAQ at a price of US$1.04 per share.<\/p>\n<p align=\"justify\">We have also been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, purchased 20,000 of the Company\u2019s ordinary shares on NASDAQ at a price of US$1.04 per share. This brings the total shareholding of Mr. Cerrone to 9,871,570 shares which is 28.96% of issued share capital.<\/p>\n<p><strong>About OKYO<\/strong><\/p>\n<p align=\"justify\">OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of NCP and DED, with ordinary shares listed for trading on the NASDAQ Capital Market. OKYO is focused on the discovery and development of novel molecules to treat NCP and inflammatory DED. In addition to the completed Phase 2 trial of OK-101 to treat DED patients, OKYO is also currently evaluating OK-101 to treat NCP patients in a Phase 2 trial.<\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:30%; width:30%; min-width:30%;;vertical-align: top ; \"><strong>Enquiries:<\/strong><\/td>\n<td style=\"max-width:40%; width:40%; min-width:40%;;vertical-align: top ; \">\u00a0<\/td>\n<td style=\"max-width:30%; width:30%; min-width:30%;;vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \"><strong>OKYO Pharma Limited<\/strong><\/td>\n<td style=\"vertical-align: top ; \"><strong>Gary S. Jacob, Chief Executive Officer<\/strong><\/td>\n<td style=\"vertical-align: top ; \"><strong>U.S. 917-497-7560<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \"><strong>Business Development &amp; Investor Relations<\/strong><\/td>\n<td style=\"vertical-align: top ; \"><strong>Paul Spencer<\/strong><\/td>\n<td style=\"vertical-align: top ; \"><strong>+44 (0)20 7495 2379<br \/><\/strong><\/td>\n<\/tr>\n<\/table>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTZiZmU1MjYtMzMyMS00OWZiLThkYTgtODZlNDY1OGJlMWUxLTEyMTI5OTY=\/tiny\/OKYO-Pharma-LTD.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON and NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease (DED), a multi-billion-dollar market, announced today that it has been [&#8230;]\n","protected":false},"author":1,"featured_media":64210,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64209","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>OKYO Pharma Announces Chairman and CEO Acquire Shares - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OKYO Pharma Announces Chairman and CEO Acquire Shares\" \/>\n<meta property=\"og:description\" content=\"LONDON and NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-31T12:01:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/OKYO-Pharma-LTD-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"OKYO Pharma Announces Chairman and CEO Acquire Shares\",\"datePublished\":\"2025-01-31T12:01:34+00:00\",\"dateModified\":\"2025-01-31T12:01:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/\"},\"wordCount\":240,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/\",\"name\":\"OKYO Pharma Announces Chairman and CEO Acquire Shares - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-01-31T12:01:34+00:00\",\"dateModified\":\"2025-01-31T12:01:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OKYO Pharma Announces Chairman and CEO Acquire Shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"OKYO Pharma Announces Chairman and CEO Acquire Shares - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/","og_locale":"en_US","og_type":"article","og_title":"OKYO Pharma Announces Chairman and CEO Acquire Shares","og_description":"LONDON and NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing","og_url":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-01-31T12:01:34+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/OKYO-Pharma-LTD-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"OKYO Pharma Announces Chairman and CEO Acquire Shares","datePublished":"2025-01-31T12:01:34+00:00","dateModified":"2025-01-31T12:01:34+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/"},"wordCount":240,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/","url":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/","name":"OKYO Pharma Announces Chairman and CEO Acquire Shares - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-01-31T12:01:34+00:00","dateModified":"2025-01-31T12:01:34+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/okyo-pharma-announces-chairman-and-ceo-acquire-shares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"OKYO Pharma Announces Chairman and CEO Acquire Shares"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64209"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64209\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64210"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}